Evidence map›Paper›PMID 28495678›Full record

ArticleThe EMBO journal2017

Sphingolipid metabolic flow controls phosphoinositide turnover at the

Serena Capasso, Lucia Sticco, Riccardo Rizzo, Marinella Pirozzi, Domenico Russo, Nina A Dathan, Felix Campelo, Josse van Galen, Maarit Hölttä-Vuori, Gabriele Turacchio and 9 more

Open access · greenAbstract read
In one paragraph

Article in The EMBO journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 99 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Lipid Sorting and Organelle Identity.Cold Spring Harbor perspectives in biology · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 6 countries.

Serena CapassoIstituto di Ricovero e Cura a Carattere Scientifico-SDN, Naples, Italy.
Lucia SticcoInstitute of Protein Biochemistry-National Research Council, Naples, Italy.
Riccardo RizzoInstitute of Protein Biochemistry-National Research Council, Naples, Italy.
Marinella PirozziInstitute of Protein Biochemistry-National Research Council, Naples, Italy.
Domenico RussoInstitute of Protein Biochemistry-National Research Council, Naples, Italy.
Nina A DathanInstitute of Protein Biochemistry-National Research Council, Naples, Italy.ORCID 0000-0001-5791-5357
Felix CampeloICFO-Institut de Ciencies Fotoniques, The Barcelona Institute of Science and Technology, Barcelona, Spain.
Josse van GalenCentre for Genomic Regulation, The Barcelona Institute of Science and Technology, Barcelona, Spain.
Maarit Hölttä-VuoriDepartment of Anatomy, Faculty of Medicine, Minerva Research Institute for Medical Research, University of Helsinki, Helsinki, Finland.
Gabriele TuracchioInstitute of Protein Biochemistry-National Research Council, Naples, Italy.
Angelika HausserInstitute of Cell Biology and Immunology, University of Stuttgart, Stuttgart, Germany.
Vivek MalhotraCentre for Genomic Regulation, The Barcelona Institute of Science and Technology, Barcelona, Spain.
Isabelle RiezmanDepartment of Biochemistry, NCCR Chemical Biology, University of Geneva, Geneva, Switzerland.
Howard RiezmanDepartment of Biochemistry, NCCR Chemical Biology, University of Geneva, Geneva, Switzerland.
Elina IkonenDepartment of Anatomy, Faculty of Medicine, Minerva Research Institute for Medical Research, University of Helsinki, Helsinki, Finland.
Chiara LubertoStony Brook Cancer Center, Health Science Center, Stony Brook University, Stony Brook, NY, USA.
Seetharaman ParashuramanInstitute of Protein Biochemistry-National Research Council, Naples, Italy.
Alberto LuiniIstituto di Ricovero e Cura a Carattere Scientifico-SDN, Naples, Italy.
Giovanni D'AngeloIstituto di Ricovero e Cura a Carattere Scientifico-SDN, Naples, Italy g.dangelo@ibp.cnr.it.ORCID 0000-0002-0734-4127
Institute of Protein Biochemistry · ITSDN Istituto di Ricerca Diagnostica e Nucleare · ITUniversitat Pompeu Fabra · ESUniversity of Geneva · CHUniversity of Helsinki · FIInstitució Catalana de Recerca i Estudis Avançats · ESStony Brook University · USUniversity of Stuttgart · DE

Funding

Sphingolipids in Cancer Therapy and AngiogenesisP01CA097132 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI Daniel Canals · 2003 to 2026
$30.8M
NCI NIH HHS P01 CA097132
6 · The paper itself

Abstract

Sphingolipids are membrane lipids globally required for eukaryotic life. The sphingolipid content varies among endomembranes with pre- and post-Golgi compartments being poor and rich in sphingolipids, respectively. Due to this different sphingolipid content, pre- and post-Golgi membranes serve different cellular functions. The basis for maintaining distinct subcellular sphingolipid levels in the presence of membrane trafficking and metabolic fluxes is only partially understood. Here, we describe a homeostatic regulatory circuit that controls sphingolipid levels at the

Indexed as

HeLa CellsHomeostasisHumansModels, BiologicalPhosphatidylinositolsSphingolipidstrans-Golgi NetworkPhosphatidylinositolsSphingolipidsceramidelipid territorieslipid‐transfer proteinmembrane contact sitesPtdIns(4)P

Identifiers

PMID28495678
PMCPMC5470045
OpenAlexW2613050630

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.